Your browser doesn't support javascript.
loading
A phase III trial of exemestane plus bevacizumab maintenance therapy in patients with metastatic breast cancer after first-line taxane and bevacizumab: a GINECO group study.
Trédan, O; Follana, P; Moullet, I; Cropet, C; Trager-Maury, S; Dauba, J; Lavau-Denes, S; Diéras, V; Béal-Ardisson, D; Gouttebel, M; Orfeuvre, H; Stefani, L; Jouannaud, C; Bürki, F; Petit, T; Guardiola, E; Becuwe, C; Blot, E; Pujade-Lauraine, E; Bachelot, T.
Afiliación
  • Trédan O; Department of Medical Oncology, Centre Léon Bérard, Lyon; CNRS UMR5286, Cancer Research Center of Lyon, Lyon.
  • Follana P; Department of Medical Oncology, Centre Antoine Lacassagne, Nice.
  • Moullet I; Department of Medical Oncology, Clinique de la Sauvegarde, Lyon.
  • Cropet C; Direction of Clinical Research and Innovation, Centre Léon Bérard, Lyon.
  • Trager-Maury S; Department of Medical Oncology, Centre Hospitalier de Senlis, Senlis.
  • Dauba J; Department of Medical Oncology, Hôpital Mont-De-Marsan, Mont-De-Marsan.
  • Lavau-Denes S; Department of Medical Oncology, CHU Dupuytren, Limoges.
  • Diéras V; Department of Medical Oncology, Institut Curie, Paris.
  • Béal-Ardisson D; Department of Medical Oncology, Hôpital Privé Jean Mermoz, Lyon.
  • Gouttebel M; Department of Medical Oncology, Hôpitaux Drôme Nord, Site de Romans, Romans-sur-Isère.
  • Orfeuvre H; Department of Medical Oncology, Hôpital Fleyriat, Bourg-en Bresse.
  • Stefani L; Department of Medical Oncology, Centre Hospitalier de la Région d'Annecy, Pringy.
  • Jouannaud C; Department of Medical Oncology, Institut Jean Godinot, Reims.
  • Bürki F; Department of Medical Oncology, Clinique de l'Union, Saint-Jean.
  • Petit T; Department of Medical Oncology, Centre Paul Strauss, Strasbourg.
  • Guardiola E; Department of Medical Oncology, Centre Hospitalier la Dracénie, Draguignan.
  • Becuwe C; Department of Medical Oncology, Oracle, Centre d'Oncologie de Gentilly, Nancy.
  • Blot E; Department of Medical Oncology, Centre Hospitalier Bretagne Atlantique, Vannes.
  • Pujade-Lauraine E; Université Paris Descartes, AP-HP, Hôpitaux Universitaires Paris Centre, Site Hôtel-Dieu, Paris, France.
  • Bachelot T; Department of Medical Oncology, Centre Léon Bérard, Lyon; CNRS UMR5286, Cancer Research Center of Lyon, Lyon. Electronic address: thomas.bachelot@lyon.unicancer.fr.
Ann Oncol ; 27(6): 1020-1029, 2016 06.
Article en En | MEDLINE | ID: mdl-26916095
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptor ErbB-2 / Receptor alfa de Estrógeno / Bevacizumab / Androstadienos Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2016 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptor ErbB-2 / Receptor alfa de Estrógeno / Bevacizumab / Androstadienos Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2016 Tipo del documento: Article Pais de publicación: Reino Unido